Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
SWM - As of  05/21/24, 03:30:40 AM:   21 Insider Transactions.

Sector: Consumer Goods    Industry: Paper & Paper Products
Prev Close:$36.15  Avg Vol(3m): 170,346  P/E: 12.00  EPS: 3.01

Email this page to a friend.    Insider Transactions for SWM

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-02-14 11:07:35.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 5.68% view
S 2020-03-13 16:22:55.0 Revance Therapeutics RVNC GIC Private Ltd 7.2% view
S 2020-02-05 15:17:54.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 6.7% view
B 2020-01-08 15:11:05.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 11.44% view
S 2019-08-12 16:09:31.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 4.81% view
S 2019-02-14 07:53:43.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 4.2% view
B 2019-02-12 10:00:55.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 8.7% view
S 2019-01-29 13:56:12.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 8.0% view
B 2019-01-04 09:29:11.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 10.38% view
S 2018-04-09 17:28:57.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 4.8% view
S 2018-02-08 12:09:49.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 9.5% view
S 2018-02-07 15:02:00.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 5.9% view
B 2018-01-23 17:08:53.0 Revance Therapeutics RVNC BlackRock Inc 7.1% view
S 2017-02-09 13:19:19.0 Revance Therapeutics RVNC NovaQuest Pharma Opportunities Fund III 10.9% view
B 2017-02-03 12:50:47.0 Revance Therapeutics RVNC BlackRock Inc 7.1% view
B 2017-01-11 12:49:32.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 16.4% view
S 2016-02-10 13:40:28.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 11.1% view
B 2016-01-28 15:59:50.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 7.16% view
B 2016-01-21 16:54:02.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 10.4% view
S 2015-02-17 07:53:29.0 Revance Therapeutics RVNC Visium Asset Management 4.2% view
B 2015-01-09 13:09:19.0 Revance Therapeutics n/a Visium Asset Management 6.1% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.